Device Trial Radar · NCT07214545
External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Oct 6, 2025
Primary completion
Sep 2027
Study completion Jan 31, 2028
Sponsor
- Lead sponsor
- University of California, San FranciscoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 9, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 7 years, up to 14 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are: * Does eTNS reduce ADHD symptoms? * Does eTNS improve core and associated features of ASD? Participation spans 8-12 weeks and includes: * 4-5 in-person visits * 4 brief virtual check-ins * Nightly use of the eTNS device with a small sticky patch applied to child's forehead * Randomized assignment (those who start with the sham device may try the active device later)
Conditions
- Attention Deficit Disorder With Hyperactivity (ADHD)
- Autism Spectrum Disorder (ASD)
Interventions
Trigeminal Nerve StimulationDevice
This intervention is expected to have an effect following a treatment period of 6 weeks.
Sham Trigeminal Nerve StimulationDevice
This intervention is NOT expected to have an effect following a treatment period of 6 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in ADHD SymptomsTime frame: Baseline to end of treatment at 6 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
UCSF Nancy Friend Pritzker Psychiatry Building
San Francisco, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.